Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2
Prabha Shrestha, David A. Davis, Hannah K. Jaeger, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 1, pp. e1009091-e1009091
Open Access | Times Cited: 24

Showing 24 citing articles:

HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus
Kathryn Lurain, Ramya Ramaswami, Laurie T. Krug, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 11
Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?
Blossom Damania, Dirk P. Dittmer
Journal of Medical Virology (2023) Vol. 95, Iss. 5
Open Access | Times Cited: 18
Intercellular adhesion molecule-1 (ICAM-1): From molecular functions to clinical applications in cancer investigation
Wen‐Jing Qian, Jinshan Yan, Xiaoyu Gang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189187-189187
Closed Access | Times Cited: 6
An atlas of chromatin landscape in KSHV-infected cells during de novo infection and reactivation
Tomoki Inagaki, Ashish Kumar, Somayeh Komaki, et al.
Virology (2024) Vol. 597, pp. 110146-110146
Open Access | Times Cited: 5
Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease
Prabha Shrestha, Yana Astter, David A. Davis, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Recent Advances in Developing Treatments of Kaposi’s Sarcoma Herpesvirus-Related Diseases
Eleonora Naimo, Jasmin Zischke, Thomas F. Schulz
Viruses (2021) Vol. 13, Iss. 9, pp. 1797-1797
Open Access | Times Cited: 27
Targeting Ikaros and Aiolos with pomalidomide fails to reactivate or induce apoptosis of the latent HIV reservoir
Rachel D. Pascoe, Youry Kim, Ajantha Rhodes, et al.
Journal of Virology (2025)
Open Access
Primary effusion lymphoma: therapeutic strategies targeting viral and cellular mechanisms
Soumaiah Abou Staiteieh, Nouria Faddoul, Berthe Hayar, et al.
Expert Review of Anticancer Therapy (2025)
Closed Access
Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection
Ramya Ramaswami, Mark N. Polizzotto, Kathryn Lurain, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 5, pp. 840-850
Open Access | Times Cited: 21
CDK4/6 inhibitors sensitize gammaherpesvirus-infected tumor cells to T-cell killing by enhancing expression of immune surface molecules
Yiquan Wu, Prabha Shrestha, Natalie M. Heape, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 15
Co-Infection of the Epstein–Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus
Michelle Böni, Lisa Rieble, Christian Münz
Viruses (2022) Vol. 14, Iss. 12, pp. 2709-2709
Open Access | Times Cited: 15
Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms
Hao Guo, Jingyi Yang, Haoran Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
KSHV vIL-6 enhances inflammatory responses by epigenetic reprogramming
Tomoki Inagaki, Kang-Hsin Wang, Ashish Kumar, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011771-e1011771
Open Access | Times Cited: 6
The role of viruses in HIV-associated lymphomas
Kathryn Lurain, Ramya Ramaswami, Robert Yarchoan
Seminars in Hematology (2022) Vol. 59, Iss. 4, pp. 183-191
Open Access | Times Cited: 9
Natural killer cell responses to human oncogenic γ-herpesvirus infections
Christian Münz
Seminars in Immunology (2022) Vol. 60, pp. 101652-101652
Open Access | Times Cited: 8
E3 Ubiquitin Ligases in Gammaherpesviruses and HIV: A Review of Virus Adaptation and Exploitation
Jessica Oswald, Mathew Constantine, Adedolapo Adegbuyi, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1935-1935
Open Access | Times Cited: 3
HHV-8 associated lymphoma
Éric Oksenhendler, Véronique Meignin
Current Opinion in Oncology (2022) Vol. 34, Iss. 5, pp. 432-438
Closed Access | Times Cited: 5
Natural Killer Cell Responses during Human γ-Herpesvirus Infections
Christian Münz
Vaccines (2021) Vol. 9, Iss. 6, pp. 655-655
Open Access | Times Cited: 7
Mechanism and therapeutic implications of pomalidomide-induced immune surface marker upregulation in EBV-positive lymphomas
Hannah K. Jaeger, David A. Davis, Ashwin Nair, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Hypoxia-sensitive cells trigger NK cell activation via the KLF4-ASH1L-ICAM-1 axis, contributing to impairment in the rat epididymis
Jitao Zeng, Weiwu Gao, Ying Tang, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113442-113442
Open Access | Times Cited: 2
Druggable host gene dependencies in primary effusion lymphoma
Neil Kuehnle, Eva Gottwein
Current Opinion in Virology (2022) Vol. 56, pp. 101270-101270
Open Access | Times Cited: 3
IRG1/ACOD1 promotes neutrophil reverse migration and alleviates local inflammation
Jingjing Ji, Hanhui Zhong, Yuehua Li, et al.
Journal of Leukocyte Biology (2024) Vol. 116, Iss. 4, pp. 854-863
Closed Access
Data from Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection
Ramya Ramaswami, Mark N. Polizzotto, Kathryn Lurain, et al.
(2023)
Open Access
Data from Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection
Ramya Ramaswami, Mark N. Polizzotto, Kathryn Lurain, et al.
(2023)
Open Access
Page 1

Scroll to top